Published • loading... • Updated
New therapies help people with schizophrenia – but access is woefully inadequate
Cognitive remediation and related therapies improve memory and daily functioning, but a WHO report says roughly two-thirds of patients receive no specialized care.
- The World Health Organization reported that cognitive therapies improve daily functioning for people with schizophrenia, yet limited access prevents many from receiving specialized care.
- Emil Kraepelin, a German psychiatrist, first described schizophrenia in 1899 under the label "dementia praecox." The DSM's diagnostic criteria today still rely on signs Kraepelin identified more than 125 years ago.
- Studies show cognitive remediation techniques improve memory and problem-solving in more than 100 controlled trials. Training in social cognitive skills teaches people with schizophrenia to think more flexibly and understand their world differently.
- While approximately 40% of diagnosed individuals have mild or no symptoms, schizophrenia remains a leading cause of disability, affecting roughly 1 in 5 homeless people and 15% of U.S. state prison inmates.
- Unfortunately, many people with schizophrenia globally do not receive specialized treatment. Until these therapies become more accessible, improvements in daily functioning will remain poorer than they should be.
Insights by Ground AI
42 Articles
42 Articles
The Conversation+39 Reposted by 39 other sources
New therapies help people with schizophrenia – but access is woefully inadequate
Schizophrenia is among the top 10 leading causes of disability, according to the World Health Organization. ATHVisions/E+ via Getty ImagesIt’s common to hear casual descriptions of “schizophrenic” behavior, describing a person oscillating between two extremes. “I really want that luxurious Italian cashmere sweater,” followed by “What am I saying? I can’t even afford a $20 polyester top right now!” I’m a professor of psychology who studies cognit…
·Boston, United States
Read Full Article
Prevalence of Anxiety, Depressive Symptoms, and Substance Use in Schizophrenia
There is a critical need for early screening and comprehensive management of anxiety and depressive symptoms in schizophrenia, as their presence significantly correlates with illness severity and may shape long-term functional outcomes.
Coverage Details
Total News Sources42
Leaning Left5Leaning Right12Center21Last UpdatedBias Distribution55% Center
Bias Distribution
- 55% of the sources are Center
55% Center
13%
C 55%
R 32%
Factuality
To view factuality data please Upgrade to Premium
